State of New Jersey Common Pension Fund D’s Celldex Therapeutics CLDX Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$648K	Buy	+20,439	New	+$557K	﹤0.01%	1433
2024 Q4	–	Sell	-52,615	Closed	-$1.79M	–	1548
2024 Q3	$1.79M	Sell	52,615 -1,735	-3%	-$66.1K	0.01%	1456
2024 Q2	$2.01M	Sell	54,350 -3,459	-6%	-$131K	0.01%	1001
2024 Q1	$2.43M	Buy	+57,809	New	+$2.37M	0.01%	1480
2023 Q2	–	Sell	-55,605	Closed	-$2M	–	1653
2023 Q1	$2M	Buy	+55,605	New	+$2.4M	0.01%	1478
2019 Q3	–	Sell	-31,666	Closed	-$85K	–	1606
2019 Q2	$85K	Hold	31,666	–	–	﹤0.01%	914
2019 Q1	$156K	Sell	31,666 -1	-0%	-$5	﹤0.01%	895
2018 Q4	$94K	Hold	31,667	–	–	﹤0.01%	908
2018 Q3	$214K	Hold	31,667	–	–	﹤0.01%	913
2018 Q2	$239K	Hold	31,667	–	–	﹤0.01%	940
2018 Q1	$1.11M	Hold	31,667	–	–	﹤0.01%	848
2017 Q4	$1.35M	Hold	31,667	–	–	0.01%	815
2017 Q3	$1.36M	Hold	31,667	–	–	0.01%	809
2017 Q2	$1.17M	Hold	31,667	–	–	﹤0.01%	810
2017 Q1	$1.72M	Hold	31,667	–	–	0.01%	757
2016 Q4	$1.68M	Hold	31,667	–	–	0.01%	753
2016 Q3	$1.92M	Hold	31,667	–	–	0.01%	734
2016 Q2	$2.08M	Hold	31,667	–	–	0.01%	717
2016 Q1	$1.8M	Hold	31,667	–	–	0.01%	729
2015 Q4	$7.45M	Hold	31,667	–	–	0.03%	475
2015 Q3	$5.01M	Buy	31,667 +4,334	+16%	+$1.23M	0.02%	557
2015 Q2	$10.3M	Hold	27,333	–	–	0.04%	420
2015 Q1	$11.4M	Hold	27,333	–	–	0.04%	408
2014 Q4	$7.48M	Hold	27,333	–	–	0.03%	506
2014 Q3	$5.31M	Hold	27,333	–	–	0.02%	555
2014 Q2	$6.69M	Buy	+27,333	New	+$6.17M	0.03%	505

Other funds holding CLDX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

State of New Jersey Common Pension Fund D's CLDX Position: Q1 2026 in Review

State of New Jersey Common Pension Fund D opened a new position in Celldex Therapeutics (CLDX) in Q1 2026: 20,439 shares worth $648K. The stake represents ﹤0.01% of the portfolio and ranks #1433 among its holdings. This is a return to the name: State of New Jersey Common Pension Fund D previously reported a position in CLDX as recently as Q3 2024.

State of New Jersey Common Pension Fund D first reported a position in CLDX in Q2 2014 and has held it in 26 quarters since. The position peaked at $11.4M in Q1 2015. 228 funds tracked by Wall St. Rank hold CLDX as of Q1 2026.

State of New Jersey Common Pension Fund D held 20,439 shares of Celldex Therapeutics worth $648K as of Q1 2026.
Celldex Therapeutics was a new State of New Jersey Common Pension Fund D position in Q1 2026.
Celldex Therapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q1 2026, its #1433 holding.
State of New Jersey Common Pension Fund D first reported a position in Celldex Therapeutics in Q2 2014 and has held it in 26 quarters since.
State of New Jersey Common Pension Fund D's Celldex Therapeutics position peaked at $11.4M in Q1 2015.
228 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q1 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q1 2026, filed 5 May 2026.